| Literature DB >> 36071413 |
Riikka Rainio1, Riitta Ahonen2, Elina Lämsä2, Johanna Timonen2.
Abstract
BACKGROUND: Pharmacies play the key role in implementing generic substitution (GS) and counselling customers about it. This study aimed to explore dispensers' perceptions of the factors that facilitate or hinder counselling customers on GS and the reference price system (RPS) in community pharmacies. It also studied dispensers' opinions about the benefits and problems of these systems and discusses them from the counselling point of view.Entities:
Keywords: Benefits; Community pharmacy; Generic substitution; Interchangeable medicines; Patient counselling; Problems; Reference price system
Mesh:
Year: 2022 PMID: 36071413 PMCID: PMC9454142 DOI: 10.1186/s12913-022-08477-2
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.908
Characteristics of the respondents and the target population
| Responding dispensers | Target dispensers | |
|---|---|---|
| Female | 466 (94.5) | 3095 (95.1) |
| Male | 27 (5.5) | 158 (4.9) |
| n = 3253 | ||
| ≤ 29 | 77 (15.5)* | 372 (11.4)* |
| 30–39 | 133 (26.8) | 889 (27.3) |
| 40–49 | 133 (26.8) | 994 (30.6) |
| 50–59 | 121 (24.4) | 841 (25.9) |
| ≥ 60 | 32 (6.5) | 157 (4.8) |
| n = 493c | ||
| ≤ 30,000 | 38 (7.7) | |
| 30,001–60,000 | 76 (15.4) | |
| 60,001–100,000 | 154 (31.2) | |
| ≥ 100,001 | 225 (45.6) | |
| Southern Finland | 148 (30.1) | |
| Southwest Finland | 58 (11.8) | |
| Western and Inland Finland | 130 (26.4) | |
| Eastern Finland | 88 (17.9) | |
| Northern Finland | 48 (9.8) | |
| Lapland | 20 (4.1) |
aRepresentativeness was analyzed in terms of the respondent’s age and gender
bInformation based on the register of the Finnish Pharmacists’ Association in January 2018
cSome of the respondents did not report their gender, age, number of prescriptions per year at the pharmacy or the location of the pharmacy
* p-value = 0.009, Chi-square test
Factors facilitating counselling about generic substitution (GS) and the reference price system (RPS)
| | |
|---|---|
| Awareness of GS and RPS | 64 (46.4) |
| Interested in the subject, responsive to information, or a positive attitude towards GS and RPS | 55 (39.9) |
| Ability to understand the GS and RPS counselling | 25 (18.1) |
| Other (e.g. customer’s financial situation, age) | 14 (10.1) |
| The information systems provide (clearly and easily) information on interchangeable medicines | 71 (66.4) |
| Systems are easy to use, simple and function well | 25 (23.4) |
| Other (e.g. computer screen helps to illustrate the counselling) | 14 (13.1) |
| Price (e.g. large price differences between preparations, stability of price changes) | 59 (72.0) |
| Similar names of interchangeable medicines | 8 (9.8) |
| Familiar or reliable manufacturer | 6 (7.3) |
| Interchangeable alternatives for the medicine available within the reference price band | 5 (6.1) |
| Other (e.g. the medicine is new to the customer, a local medicine brand) | 13 (15.9) |
| The medicine is in stock at the pharmacy | 42 (68.9) |
| The medicine is available from a wholesaler | 17 (27.9) |
| The medicine is available | 13 (21.3) |
| Dispenser’s competence in GS and RPS (e.g. knowledge of GS and the RPS) | 18 (60.0) |
| Dispenser can provide clear counselling | 8 (26.7) |
| Dispenser recognizes the counselling as a legal obligation | 7 (23.3) |
| Other (e.g. dispenser’s own activeness) | 2 (6.7) |
| Clear instructions for GS | 8 (13.1) |
| Prescription-related subjects | 8 (13.1) |
| Information from wholesalers | 3 (4.9) |
| Other | 42 (68.9) |
aRespondents could list several factors; b Percentages of respondents in the main categories are calculated from the respondents to the question (n = 378), percentages of respondents in subcategories are calculated within its main category
Factors hindering counselling about generic substitution (GS) and the reference price system (RPS)
| | |
|---|---|
| Difficulties in understanding GS and/or RPS | 93(45.8) |
| Prejudice, lack of interest or negative attitude | 57 (28.1) |
| Difficulties in communication | 41 (20.2) |
| Prefer physician’s choice of the product | 23 (11.3) |
| Unaware of GS or RPS | 18 (8.9) |
| Not the user of the medicine | 11 (5.4) |
| Other (e.g. age, illnesses, lots of medicines) | 34 (16.7) |
| The medicine is not available in the pharmacy or from a wholesaler | 122 (84.7) |
| Need to check the availability of the medicine from a wholesaler | 18 (12.5) |
| Problems in availability after the change of reference price | 13 (9.0) |
| Small price differences between interchangeable medicines and informing customers about them | 43 (43.0) |
| Different and difficult names of the interchangeable medicines | 23 (23.0) |
| Large selection of interchangeable medicine options | 23 (23.0) |
| Other (e.g. only one or small number of interchangeable medicines in the reference price band) | 26 (26.0) |
| Constantly/frequently changing prices | 34 (47.9) |
| Changes in the reference price band and update of the new reference price | 29 (40.8) |
| Variable position of interchangeable medicines in the reference price band | 9 (12.7) |
| System is complex and difficult | 36 (63.2) |
| System is difficult to explain clearly to the customer | 13 (22.8) |
| Instructions and rules for GS and RPS are complex | 12 (21.1) |
| The necessary information is not easily or sufficiently visible (e.g. price differences between medicines), or not found at all | 29(85.3) |
| Other (e.g. the pharmacy system is complex) | 6 (17.6) |
| Matters related to dispensers (e.g. negative attitude, insufficient competence) | 6 (11.5) |
| There are lots of things to tell the customer | 4 (7.7) |
| Other | 42 (80.8) |
aRespondents could list several factors; b Percentages of respondents in the main categories are calculated from the respondents to the question (n = 443), percentages of respondents in subcategories are calculated within its main category
Benefits and problems of GS and RPS as reported by the dispensers
| Cost savings for customers and society | 354 (74.4) |
| Lower medicine prices and price competition | 106 (22.3) |
| Improved availability in medicine shortages | 92 (19.3) |
| Customer has the right to decide on GS and the freedom to choose the product | 65 (13.7) |
| Improved medication adherence by choosing the most suitable preparation for the customerb and due to a lower medicine price | 33 (6.9) |
| No need to contact the physician about GS | 25 (5.3) |
| Several optional interchangeable medicines | 13 (2.7) |
| Otherc | 36 (7.6) |
| Medicine availability problems | 149 (31.9) |
| Changes in medicine prices and reference price band | 135 (28.9) |
| GS takes time and increases the workload (e.g. price counselling, explaining the system to customers, checking the availability of interchangeable products) | 113 (24.2) |
| Inventory control is challenging (e.g. not everything or even the cheapest can be kept in stock, difficulty in storage due to the unpredictability of preparations within reference price bands) | 101 (21.6) |
| Change of the preparation due to GS may pose a risk to medication safety (e.g. changes in name, packaging or appearance confuse customers, double medication, complications in keeping up to date with medicines in use) | 100 (21.4) |
| The system is complex for the customer to understand | 72 (15.4) |
| Actions by pharmaceutical companies (e.g. setting really low prices for a small batch of medicines) | 54 (11.6) |
| Customers’ suspicious or negative attitude towards GS | 42 (9.0) |
| Obligation to inform the customer about the cheapest product is frustrating (e.g. because of small price differences between products) | 33 (7.1) |
| Differences between interchangeable preparations (e.g. experienced efficacy, side effects, whether or not tablets can be split) | 30 (6.4) |
| Information systems problems (e.g. do not provide enough information about availability) | 19 (4.1) |
| Too many interchangeable medicines options | 18 (3.9) |
| Otherd | 68 (14.6) |
aRespondents could list several factors; be.g. in terms of excipients, whether or not tablets can be split, packaging; ce.g. no need to have every interchangeable preparation in stock in the pharmacy, customer satisfaction; dLower profitability and margins for pharmacies, contraceptive pills are not interchangeable. There may be a large cost to the customer if substitution is declined